Nalaganje...
Switching from an LHRH Antagonist to an LHRH Agonist: A Case Report of 10 Finnish Patients with Advanced Prostate Cancer
INTRODUCTION: Luteinizing hormone-releasing hormone (LHRH) analogues are widely used for the treatment of advanced hormone-dependent prostate cancer. However, there are currently no clinical guidelines for switching between LHRH analogues. It has been reported that there may be clinical benefits for...
Shranjeno v:
| izdano v: | Oncol Ther |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Healthcare
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5488110/ https://ncbi.nlm.nih.gov/pubmed/28680962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40487-017-0040-8 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|